(NASDAQ: IVVD) Invivyd's forecast annual revenue growth rate of 81.45% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 80.59%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.89%.
Invivyd's revenue in 2025 is $46,210,000.On average, 2 Wall Street analysts forecast IVVD's revenue for 2025 to be $8,854,525,171, with the lowest IVVD revenue forecast at $7,040,368,725, and the highest IVVD revenue forecast at $10,668,681,617. On average, 2 Wall Street analysts forecast IVVD's revenue for 2026 to be $20,358,199,324, with the lowest IVVD revenue forecast at $15,486,408,338, and the highest IVVD revenue forecast at $25,229,990,310.
In 2027, IVVD is forecast to generate $33,688,044,204 in revenue, with the lowest revenue forecast at $33,688,044,204 and the highest revenue forecast at $33,688,044,204.